LAMEA Wearable Injectors Market

LAMEA Wearable Injectors Market Size, Share & Industry Trends Analysis Report By Therapy (Diabetes, Cardiovascular disease, Immuno-oncology), By End User, By Type, By Technology, By Country and Growth Forecast, 2022 - 2028

Report Id: KBV-9480 Publication Date: May-2022 Number of Pages: 106
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support

Market Report Description

The Latin America, Middle East and Africa Wearable Injectors Market would witness market growth of 10.0% CAGR during the forecast period (2022-2028).

All of the system's internal electrical and mechanical subcomponents are located in the device body. The mechanical components' primary function is to deliver the medicine to the body at a predetermined or variable flow rate. Certain devices contain flow rate controllers that can be sent via physical mechanisms on the device or via a linked application. The flow rate is either a personal decision or a mandate of the physician. The electrical subcomponents usually enable communication along with external devices to help the patient track their progress over time. A monitoring window and audio/visual feedback are also commonly used to notify the patient when the delivery is finished.

The necessary drug volume or bolus is held in the cartridge. A glass container, a rubber seal, a rubber stopper, and an aluminum crimped cap are usually included. To effectively design the actuation mechanism, the glide force and break-loose for the stopper must be evaluated. The injection would usually be started by pressing a clearly indicated button on the device. Many variables must be addressed while designing a button, including activation force, tactical feedback, and design characteristics that prevent inadvertent actuation.

In the emirate of Abu Dhabi, chronic care services for people with diabetes, cardiovascular disease, and cancer are available in both privately and publicly funded healthcare facilities. In a survey conducted by the National Library of Medicine, twenty specialists from different healthcare systems were chosen at random. They were public and private sector front-line healthcare workers who provided care to people with diabetes, cardiovascular disease, and cancer.

In terms of size and population, Abu Dhabi is the largest emirate in the United Arab Emirates. The United Arab Emirates and the emirate of Abu Dhabi feature an atypical population pyramid, with a young population and a sex imbalance of around four times as many men as women. The significant recruitment of expatriate men working in the construction and industrial sectors has resulted in a gender imbalance in the general population. UAE nationals, on the other hand, have an equal sex ratio. Only 18.2% of Abu Dhabi residents are UAE citizens, and the bulk (67.3%) are under 30 years old. Despite having a younger population than similar high-income developed countries, the UAE is grappling with a growing problem of lifestyle-related chronic diseases, such as obesity, diabetes, cardiovascular disease, and cancer.

The Brazil market dominated the LAMEA Wearable Injectors Market by Country 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $194 Million by 2028. The Argentina market is anticipated to grow at a CAGR of 10.6% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 9.7% during (2022 - 2028).

Based on Therapy, the market is segmented into Diabetes, Cardiovascular disease, Immuno-oncology, and Others. Based on End User, the market is segmented into Hospitals & Clinics and Home healthcare setting. Based on Type, the market is segmented into On-body Injector and Off-body Injector. Based on Technology, the market is segmented into Spring Based, Motor Based, Rotary pump, Expanding battery, and others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Global Wearable Injectors Market is Predict to reach $12.9 Billion by 2028, at a CAGR of 9.2%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Insulet Corporation, United Therapeutics Corporation, ATS Automation Tooling Systems, Inc., Ypsomed AG, Amgen, Inc., West Pharmaceutical Services, Inc., Zealand Pharma A/S (Valeritas, Inc.), Medtronic PLC, CeQur SA, and Subcuject ApS.

Scope of the Study

Market Segments Covered in the Report:

By Therapy

  • Diabetes
  • Cardiovascular disease
  • Immuno-oncology
  • Others

By End User

  • Hospitals & Clinics
  • Home healthcare setting

By Type

  • On-body Injector
  • Off-body Injector

By Technology

  • Spring Based
  • Motor Based
  • Rotary pump
  • Expanding battery
  • Others

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Insulet Corporation
  • United Therapeutics Corporation
  • ATS Automation Tooling Systems, Inc.
  • Ypsomed AG
  • Amgen, Inc.
  • West Pharmaceutical Services, Inc.
  • Zealand Pharma A/S (Valeritas, Inc.)
  • Medtronic PLC
  • CeQur SA
  • Subcuject ApS
Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now


Call: +1(646) 600-5072


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo